The Supreme Court unanimously preserved access to mifepristone, a medication used in most U.S. abortions, ruling abortion opponents lack the right to sue over FDA's approval and access actions.
Justice Brett Kavanaugh stated federal courts are not the proper venue for the plaintiffs' concerns about FDA's actions regarding mifepristone, amid broader debates on abortion cases.
More than 6 million people have used mifepristone since 2000, with concerns that limiting access can impact abortion procedures and lead to decreased efficacy in ending pregnancies.
President Joe Biden's administration and drug manufacturers warned that restricting mifepristone access could set a precedent to second-guess FDA's scientific approvals outside abortion contexts.
[
add
]
[
|
|
...
]